Literature DB >> 31924488

Periprosthetic Fractures of the Distal Femur: Is Open Reduction and Internal Fixation or Distal Femoral Replacement Superior?

Brian Darrith1, Daniel D Bohl1, Mark S Karadsheh1, Scott M Sporer1, Richard A Berger1, Brett R Levine1.   

Abstract

BACKGROUND: The purpose of this study is to compare open reduction and internal fixation (ORIF) to distal femoral replacement (DFR) for treatment of displaced periprosthetic distal femur fractures.
METHODS: We identified 72 patients with minimum 2-year follow-up following a displaced periprosthetic distal femur fracture: 50 were treated with ORIF and 22 with DFR. Outcomes were assessed with multivariate regression analysis and include Knee Society Scores (KSS), infection rates, revision incidence, and mortality.
RESULTS: Patients treated with DFR had a higher Charlson comorbidity index (5.2 vs 3.8; P = .006). The mean postoperative KSS were similar between groups, but the Knee Society Functional Scores were higher in the ORIF group (P = .01). Six ORIF patients (12%) and 3 DFR patients (14%) underwent a revision surgery (P = .1). In the ORIF group, 3 revisions were associated with periprosthetic infection, and 3 revisions occurred for aseptic nonunion. In the DFR group, 1 infection was treated with irrigation and debridement, and 2 cases of patellar maltracking resulted in 1 liner exchange with soft tissue release and 1 femoral revision for malrotation. More patients in the ORIF group required repeat revisions, with twice as many total revisions (P < .001). Six ORIF patients and 7 DFR patients died within 2 years (P = .26).
CONCLUSION: The Knee Society Functional Score favored ORIF, but the total incidence of revision was higher in the ORIF cohort. Given the high mortality and the substantial risk of reoperation in both groups, additional studies are needed regarding the prevention of and optimal treatment for patients with periprosthetic distal femur fractures.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  distal femoral replacement; megaprosthesis; periprosthetic distal femur fracture; periprosthetic supracondylar femur fracture; total knee arthroplasty

Year:  2019        PMID: 31924488     DOI: 10.1016/j.arth.2019.12.033

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  Early complications and reoperation rates are similar amongst open reduction internal fixation, intramedullary nail, and distal femoral replacement for periprosthetic distal femur fractures: a systematic review and meta-analysis.

Authors:  David A Quinzi; Gabriel Ramirez; Nathan B Kaplan; Thomas G Myers; Caroline P Thirukumaran; Benjamin F Ricciardi
Journal:  Arch Orthop Trauma Surg       Date:  2021-03-20       Impact factor: 3.067

2.  A lateral parapatellar approach with iliotibial band dissection from the Gerdy tubercle for total knee arthroplasty of the valgus knee.

Authors:  Wendan Cheng; Ziyu Li; Jisen Zhang; Qiliang Cao; Haoran Yu; Lei Qi; Fei Yao; Juehua Jing
Journal:  Exp Ther Med       Date:  2020-11-17       Impact factor: 2.447

3.  Distal Femoral Replacements for Acute Comminuted Periprosthetic Knee Fractures: Satisfactory Clinical Outcomes at Medium-Term Follow-up.

Authors:  Hosam E Matar; Benjamin V Bloch; Peter J James
Journal:  Arthroplast Today       Date:  2020-12-25

Review 4.  Review of patient-reported outcomes in periprosthetic distal femur fractures after total knee arthroplasty: a plate or intramedullary nail?

Authors:  Dustin Rinehart; Tyler Youngman; Junho Ahn; Michael Huo
Journal:  Arthroplasty       Date:  2021-06-11

5.  Distal Femur Tumor Megaprosthesis for Non-union of Supracondylar Femur Fracture after Failed Osteosynthesis. An Ingenious Solution.

Authors:  Bikram Kesari Kar; Mukund Madhav Ojha; Sandeep Kumar Yadav; Alok Chandra Agrawal; Sharath Kowshik
Journal:  J Orthop Case Rep       Date:  2021-09

6.  Patient safety in distal femoral resection knee arthroplasty for non-tumor indications: a single-center consecutive cohort study of 45 patients.

Authors:  Yasemin Corap; Michael Brix; Claus Emmeluth; Martin Lindberg-Larsen
Journal:  BMC Musculoskelet Disord       Date:  2022-03-03       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.